GLP-1 Market
LLY $1427.28 ▼ -0.7% NVO $40.65 ▼ -1.1% PFE $28.83 ▼ -2.1% VKTX $27.58 ▼ -3.0% KLRA $13.21 ▼ -8.1% GPCR $19.84 ▼ -5.3% RHHBY $60.57 • 0.0%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Stiripentol

Company
Biocodex
Mechanism
Mechanism not yet reported
Route
Oral
Recruiting trials
2 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

2 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 13, 2026

Find a Clinical Trial Near Me

See recruiting studies for Stiripentol and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT06465472

    Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3

    Not yet reported Biocodex 42 participants Est. completion 2030-08 1 site Stand-alone
    Other conditions: Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 2, Primary Hyperoxaluria Type 3
    View official trial listing →
  • Recruiting NCT NCT06598449

    Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age

    Not yet reported University of Colorado, Denver 5 participants Est. completion 2027-07 1 site Stand-alone
    Other conditions: Dravet Syndrome (DS), Children Under 2 Years
    View official trial listing →
  • No Longer Available NCT NCT01533506

    Stiripentol in Dravet Syndrome

    Mayo Clinic Est. completion 2013-02 1 site
    Other conditions: Dravet Syndrome
    View official trial listing →
  • No Longer Available NCT NCT01835314

    Compassionate Use of Stiripentol in Dravet Syndrome

    University of Colorado, Denver 1 site
    Other conditions: Dravet Syndrome
    View official trial listing →
  • Approved For Marketing NCT NCT01983722

    Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome

    Children's Hospital Medical Center, Cincinnati 1 site
    Other conditions: Dravet Syndrome
    View official trial listing →
  • Status unknown NCT NCT02205931

    Ketogenic Diet in Infants With Epilepsy (KIWE)

    Not yet reported University College, London 160 participants Est. completion 2019-06 11 sites
    Other conditions: Epilepsy
    View official trial listing →
  • No Longer Available NCT NCT02239276

    Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies

    Cook Children's Health Care System 1 site
    Other conditions: Dravet Syndrome, Epileptic Encephalopathies Associated With SCN1A Mutations
    View official trial listing →
  • Completed NCT NCT02607891

    A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

    Not yet reported Jazz Pharmaceuticals 35 participants Est. completion 2018-10-02 5 sites
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02607904

    An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

    Not yet reported Jazz Pharmaceuticals 30 participants Est. completion 2019-05-27 5 sites
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT02926898

    A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome

    Not yet reported Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 87 participants Est. completion 2018-06-05 28 sites
    Other conditions: Dravet Syndrome
    View official trial listing →
  • Completed NCT NCT03196466

    Population Pharmacokinetics of Antiepileptic in Pediatrics

    Assistance Publique - Hôpitaux de Paris 753 participants Est. completion 2023-06-15 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT03819647

    Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria

    Not yet reported Biocodex 15 participants Est. completion 2021-03-08 3 sites Stand-alone
    Other conditions: Primary Hyperoxaluria
    View official trial listing →
  • Completed NCT NCT03866928

    Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers

    Not yet reported Biocodex 14 participants Est. completion 2019-04-05 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Active, not recruiting NCT NCT05064878

    A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.

    Not yet reported Zogenix, Inc. 87 participants Est. completion 2027-11-08 46 sites Stand-alone
    Other conditions: CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure, Epileptic Spasm, Refractory Seizures
    View official trial listing →
  • Completed NCT NCT05232630

    Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes

    Not yet reported Hospital Ruber Internacional 20 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Refractory Epilepsy, SYNGAP1 Encephalopathy, STXBP1 Encephalopathy With Epilepsy, Inv Dup(15) Encephalopathy, Multifocal or Bilateral Malformations of Cortical Development, Continuous Spike and Waves During Slow Sleep
    View official trial listing →
  • Completed NCT NCT05419180

    Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies

    Not yet reported Biocodex 52 participants Est. completion 2024-06-13 1 site
    Other conditions: Pharmacoresistant Focal Epilepsies
    View official trial listing →
  • Completed NCT NCT05544058

    Retrospective Non-interventional Study of Stiripentol Use in Dravet Patients in the USA

    Biocodex 100 participants Est. completion 2024-06-28 1 site
    Other conditions: Dravet Syndrome
    View official trial listing →
  • Terminated NCT NCT05560282

    Fenfluramine for Adult Dravet Patients

    Not yet reported University Health Network, Toronto 7 participants Est. completion 2025-05-13 1 site Stand-alone
    Other conditions: Dravet Syndrome, Dravet Syndrome, Intractable
    View official trial listing →
  • Completed NCT NCT05735951

    Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Function

    Not yet reported Biocodex 39 participants Est. completion 2024-11-30 1 site Stand-alone
    Other conditions: Chronic Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT06540378

    Stiripentol for the Treatment of Refractory Status Epilepticus

    University Hospital Marburg 25 participants Est. completion 2024-05
    Other conditions: Status Epilepticus
    View official trial listing →
  • Completed NCT NCT07176832

    Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ)

    Not yet reported Biocodex 24 participants Est. completion 2025-08-27 2 sites Stand-alone
    Other conditions: Dravet Syndrome, Epilepsy, Childhood, Epileptic Encephalopathy, Pediatric Epilepsy
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Stiripentol, Diacomit, Stiripentol Oral Capsule

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.